Four researchers share the latest on Fragile X research, clinical trials and support tools. Professor David Hessl covers the International Fragile X Premutation Registry, Associate Professor Jessica Klusek shares what's being learned about the FMR1 premutation in women, Associate Professor Erin Turbitt gives an update on the NurtureNextGen project, and Katie Clapp from FRAXA Research Foundation covers the latest clinical trial pipeline.

00:42 Professor David Hessl: International Fragile X Premutation Registry
13:25 Associate Professor Jessica Klusek: The FMR1 Premutation in Women
33:23 Associate Professor Erin Turbitt: The NurtureNextGen Project
46:07 Katie Clapp: FRAXA Research Foundation, research and clinical trial update

Rss
Podden och tillhörande omslagsbild på den här sidan tillhör Fragile X Australia. Innehållet i podden är skapat av Fragile X Australia och inte av, eller tillsammans med, Poddtoppen.